David Tuller (University of California, Berkeley), Steven Lubet (Northwestern University), and I have written an opinion piece over at Health Affairs. It’s on the implications of recent developments in ME and chronic fatigue syndrome for the treatment of Long COVID. We argue that the paradigm shift signalled by the UK’s […]
Last October, I wrote that COVID-19 had created a stampede of shoddy research. Little has changed in the interim. Putting all hands to the pump might feel appropriate in a crisis, but during a global public health emergency, rushing headlong into the scholarly frontline is anything but okay. Frankly, it is […]
Swiss Re Group, “one of the world’s leading providers of reinsurance and insurance,” recently hosted a virtual Expert Forum on “secondary” impacts of COVID. As would be expected, the insurance industry is especially interested in the financial implications of this new disease. The programme covered many of the biophysical sequelae […]
